Consistent with previous reports (Blicket al, 2008; Taubeet al, 2010), we observed that Luminal-A, Luminal-B and ERBB2+ breast cancers were more Epi (P = 0.0496,P = 3.34E-79 andP = 2.48E-6, respectively), whereas Basal and Claudin-Low breast cancers were more Mes (P = 1.98E-40 andP = 2.47E-68, respectively) in both non-LCM and LCM cohorts. Here, ERBB2 is linked to breast carcinoma.